GYNOREST Drug Patent Profile
✉ Email this page to a colleague
When do Gynorest patents expire, and what generic alternatives are available?
Gynorest is a drug marketed by Solvay and is included in one NDA.
The generic ingredient in GYNOREST is dydrogesterone. There is one drug master file entry for this compound. Additional details are available on the dydrogesterone profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for GYNOREST?
- What are the global sales for GYNOREST?
- What is Average Wholesale Price for GYNOREST?
Summary for GYNOREST
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 67 |
| Patent Applications: | 2,009 |
| DailyMed Link: | GYNOREST at DailyMed |
US Patents and Regulatory Information for GYNOREST
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Solvay | GYNOREST | dydrogesterone | TABLET;ORAL | 017388-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Solvay | GYNOREST | dydrogesterone | TABLET;ORAL | 017388-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
